Clinical Trial Update: SGLT-2 Inhibitors on Albuminuria in Chronic Kidney Disease Patients With Lupus Nephritis and ANCA- Associated Vasculitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the impact of SGLT-2 inhibitors on albuminuria in chronic kidney disease patients with lupus nephritis and ANCA-associated vas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis
• Lupus Nephritis

Drugs mentioned

• SGLT-2 inhibitors

Snippet

Sponsor: Federico II University | Conditions: Lupus Nephritis (LN), ANCA Associated Vasculitis (AAV) | Phase 4 | Status: NOT_YET_RECRUITING